A Network Pharmacology and Experimental Validation Strategy for Hypoglycemic Study of Lonicerae Japonicae Flos on Diabetes
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Zhang Nan und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Henan Medical University, Xinxiang, Henan Province, China. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Network Pharmacology, Lonicera, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Key Research Projects of Henan Province, Backbone Teachers Program of Sanquan College of Xinxiang Medical University (North Henan Medical University), Key Laboratory of Asymmetric Synthesis and Chiral Technology of Sichuan Province.
Themen: Diabetes mellitus
Abstract (Originalsprache)
As diabetes has become an important public health issue, Lonicerae Japonicae Flos (LJF) had gradually attracted increasing attention on diabetes. This study aimed to investigate the hypoglycemic ingredients and underlying mechanisms of LJF in diabetes using an integrated strategy of network pharmacology, molecular docking and experimental validation. Network pharmacology screened 73 active ingredients, 65 targets and 20 main signalling pathways. The results of molecular docking, protein–protein interaction and ingredient‐target‐pathway network indicated that four targets (PPARG, PPARD, MGAM, GAA) and three signalling pathways (PPAR signalling pathway, Starch and sucrose metabolism, Galactose metabolism) played essential roles. Subsequently, animal experiments and in vitro tests were performed to evaluate the anti‐diabetic effect, antioxidant capacity and α‐amylase inhibitory activity for the LJF extract. Animal studies indicated the LJF alcohol extract could significantly decrease blood glucose level and mitigate the weight loss compared to the model group ( p < 0.05), respectively. Furthermore, both in vitro and in vivo tests confirmed that the LJF alcohol extract exhibited strong antioxidant capacity ( p < 0.05 for MDA and SOD) and α‐amylase inhibitory activity (maximum efficacy: 66.6% ± 4.6%). This strategy provided a promising approach to further elucidate the active ingredients and underlying mechanisms of LJF and other herbs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Henan Medical University, Xinxiang, Henan Province, China.
- Experimental Teaching Center of Biology and Basic Medicine, North Henan Medical University, Xinxiang, Henan Province, China.
Förderung
- University Key Research Projects of Henan Province
- Backbone Teachers Program of Sanquan College of Xinxiang Medical University (North Henan Medical University)
- Key Laboratory of Asymmetric Synthesis and Chiral Technology of Sichuan Province
- Natural Science Foundation of Henan Province
- Key Scientific Research Projects of Higher Education Institutions in Henan Province
- Key Research and Development Program of Henan
Zitieren
APA
Nan, Z., Xiaolong, L., Chunyan, L., Lu, R., Chao, G., & Jintao, X. (2026). A Network Pharmacology and Experimental Validation Strategy for Hypoglycemic Study of Lonicerae Japonicae Flos on Diabetes. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71167
Vancouver
Nan Z, Xiaolong L, Chunyan L, Lu R, Chao G, Jintao X. A Network Pharmacology and Experimental Validation Strategy for Hypoglycemic Study of Lonicerae Japonicae Flos on Diabetes. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71167
BibTeX
@article{Nan2026,
author = {Nan, Zhang and Xiaolong, Liu and Chunyan, Li and Lu, Ren and Chao, Guo and Jintao, Xue},
title = {A Network Pharmacology and Experimental Validation Strategy for Hypoglycemic Study of Lonicerae Japonicae Flos on Diabetes},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71167}
}
EUVIMED